Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study)

OBJECTIVES: People with epilepsy have greater cognitive and behavioral dysfunction than the general population. There is no specific treatment available for cognitive impairment of these patients. We aimed to evaluate the effects of memantine, an N-methyl-D-aspartate-type glutamate receptor noncompe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Indian Acad Neurol
Autors principals: Marimuthu, Priya, Varadarajan, Sathyanarayanan, Krishnan, Muthuraj, Shanmugam, Sundar, Kunjuraman, Gireesh, Ravinder, Jamuna Rani, Arumugam, Balasubramanian, Alex, Divya, Swaminathan, Porchelvan
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980957/
https://ncbi.nlm.nih.gov/pubmed/27570386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-2327.179971
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars